- 5
- 0
- 约1.82万字
- 约 25页
- 2023-09-21 发布于湖北
- 举报
Clinical evidence for high-risk
cardiovascular medical devices
A systematic evaluation of the CORE-MD Consortium
Stephan Windecker
G Siontis, B Coles, J Häner, L McGovern, J Bartkowiak, JJ Coughlan, A Spirito, R Galea,
A Haeberlin, F Praz, D Tomii, T Melvin, A Frenk, R Byrne, A Fraser, for the CORE-MD investigators
28 August 2023
Disclosure Statement of Financial Interest
• Research and educational grants to the institution from Abbott,
Abiomed, Amgen, Astra Zeneca, Bayer, Biotronik, Boehringer Ingelheim,
Boston Scientific, Bristol Myers Squibb, Cardinal Health, CardioValve,
原创力文档

文档评论(0)